Clinical Trial

Evaluating Gingivitis and Systemic Biomarkers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 3, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This exploratory study will consist of two parts: Phase 1 (sample collection/screening) and Phase 2 (sample collection/product efficacy testing). The purpose of Phase 1 is to understand the association of gingivitis to systemic biomarkers and to screen subjects for Phase 2. The purpose of Phase 2 is to assess the causal effect of oral hygiene intervention on gingivitis and systemic biomarkers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-30.
Status change: Recruiting → Active, Not Recruiting 2025-06-02
Trial Details
NCT Number NCT06962956
Lead Sponsor Procter and Gamble
Conditions Gingivitis
Enrollment 135 participants
Start Date 2025-04-30
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-03